Adagrasib Improves PFS Over Docetaxel in Patients with Previously Treated KRASG12C-mutated NSCLC By Ogkologos - August 20, 2025 428 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KRYSTAL-12 study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative... February 27, 2025 Ovarian cancer screening trial did not save lives May 12, 2021 Inequalities cause 2,000 extra cancer cases in Wales June 8, 2023 Liquid Biopsy May Predict Risk of Breast Cancer Returning Years Later August 15, 2018 Load more HOT NEWS The Largest Randomised Study to Date Points to Low Ipsilateral Breast... Foster Teen With A Passion For Painting Is Patiently Waiting For... ΤΙ ΕΙΝΑΙ Breast Cancer Risk Genes
